Science Explorer Back to mapMap
Institution · Rosa (United States)

Most cited papers from Rosa (United States)

What are the most cited papers from Rosa (United States)?

The most cited paper from Rosa (United States) is "Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome" (Siamak MahmoudianDehkordi et al., 2018), with 720 citations. Next come "Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study" (508) and "Metabolic network failures in Alzheimer's disease: A biochemical road map" (507).

Showing 50 of 59 papers. Every paper with more than 3 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome Siamak MahmoudianDehkordi et al. · Alzheimer s & Dementia Open access 15 Oct 2018 720
2 Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study Vijay R. Varma, Anup Mammen Oommen, Sudhir Varma et al. · PLoS Medicine Open access 25 Jan 2018 508
3 Metabolic network failures in Alzheimer's disease: A biochemical road map Jon B. Toledo et al. · Alzheimer s & Dementia Open access 21 Mar 2017 507
4 Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers Kwangsik T. Nho et al. · Alzheimer s & Dementia Open access 15 Oct 2018 350
5 Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers Kwangsik T. Nho, Alexandra Kueider‐Paisley, Shahzad Ahmad et al. · JAMA Network Open Open access 31 Jul 2019 244
6 Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome Matthias Arnold et al. · Nature Communications Open access 2 Mar 2020 223
7 Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment Rima F Kaddurah-Daouk, Rebecca Baillie, Hongjie Zhu et al. · PLoS ONE Open access 13 Oct 2011 194
8 Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease Emrin Horgusluoglu et al. · Alzheimer s & Dementia Open access 10 Nov 2021 184
9 Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer’s disease Kevin Huynh et al. · Nature Communications Open access 10 Nov 2020 170
10 Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics Joseph P. McEvoy, Rebecca Baillie, Hongjie Zhu et al. · PLoS ONE Open access 24 Jul 2013 131
11 Serum triglycerides in Alzheimer disease Megan M. Bernath, Sudeepa Bhattacharyya, Kwangsik T. Nho et al. · Neurology Open access 2 May 2020 125
12 Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer’s disease Priyanka Baloni et al. · Communications Biology Open access 8 Oct 2022 112
13 Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study Rima F Kaddurah-Daouk, Rebecca Baillie, Hongjie Zhu et al. · Metabolomics Open access 31 Mar 2010 108
14 Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature Christopher R. Brydges et al. · Scientific Reports Open access 25 Oct 2021 102
15 Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression Siamak MahmoudianDehkordi et al. · Translational Psychiatry Open access 2 Mar 2021 102
16 Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment Miles Trupp, Hongjie Zhu, William R. Wikoff et al. · PLoS ONE Open access 9 Jul 2012 101
17 Impaired plasmalogens in patients with schizophrenia Rima F Kaddurah-Daouk, Joseph P. McEvoy, Rebecca Baillie et al. · Psychiatry Research 16 Apr 2012 90
18 A model qualification method for mechanistic physiological QSP models to support model‐informed drug development Christoph M. Friedrich · CPT Pharmacometrics & Systems Pharmacology Open access 26 Jan 2016 87
19 Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology Dinesh Kumar Barupal, Rebecca Baillie, Sili Fan et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring Open access 5 Sep 2019 76
20 Hereditary Pancreatitis P.R. Davidson, DAVID COSTANZA, JOHN A. SWIECONEK et al. · Annals of Internal Medicine 1968 55
21 APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies Tingting Wang et al. · Alzheimer s & Dementia Open access 25 Jan 2022 51
22 Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level Ronald B. Moss, Meghan McCabe Pryor, Rebecca Baillie et al. · PLoS ONE Open access 16 Jun 2020 47
23 Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression Kwangsik T. Nho, Alexandra Kueider‐Paisley, Matthias Arnold et al. · Brain Communications Open access 2021 46
24 Peripheral serum metabolomic profiles inform central cognitive impairment Jingye Wang, Runmin Wei, Guoxiang Xie et al. · Scientific Reports Open access 20 Aug 2020 40
25 FDA-Industry Scientific Exchange on assessing quantitative systems pharmacology models in clinical drug development: a meeting report, summary of challenges/gaps, and future perspective Jane P. F. Bai, Brian James Schmidt, Kapil G. Gadkar et al. · The AAPS Journal 30 Apr 2021 39
26 Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau Mitchel Allan Kling, Dayan B. Goodenowe, Vijitha K. Senanayake et al. · Alzheimer s & Dementia Open access 27 Jul 2020 36
27 Plasma Omega-3 Polyunsaturated Fatty Acids and Survival in Patients with Chronic Heart Failure and Major Depressive Disorder for the SADHART-CHF Investigators, Wei Jiang, Harry A. Oken et al. · Journal of Cardiovascular Translational Research Nov 2011 34
28 Peripheral inflammation is associated with brain atrophy and cognitive decline linked to mild cognitive impairment and Alzheimer’s disease Nuanyi Liang et al. · Scientific Reports Open access 29 Jul 2024 28
29 Human CD4+CD25+CD226- Tregs Demonstrate Increased Purity, Lineage Stability, and Suppressive Capacity Versus CD4+CD25+CD127lo/- Tregs for Adoptive Cell Therapy Matthew E. Brown, Leeana D. Peters, Seif R. Hanbali et al. · Frontiers in Immunology Open access 26 May 2022 27
30 Is a Diabetes Mellitus–Linked Amino Acid Signature Associated With β-Blocker–Induced Impaired Fasting Glucose? Rhonda M. Cooper‐DeHoff, Wei Hou, Liming Weng et al. · Circulation Cardiovascular Genetics Open access 13 Mar 2014 25
31 Systems Biology Richard Ho, Christopher A. Lieu · Drugs in R&D 2008 25
32 Quantitative systems pharmacology model of the amyloid pathway in Alzheimer's disease: Insights into the therapeutic mechanisms of clinical candidates Vidya Ramakrishnan, Christina M. Friedrich, Colleen M. Witt et al. · CPT Pharmacometrics & Systems Pharmacology Open access 25 Oct 2022 22
33 Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics Mohamed H. Shahin, Yan Gong, Reginald F. Frye et al. · Journal of the American Heart Association Open access 30 Dec 2017 22
34 Using machine learning surrogate modeling for faster QSP VP cohort generation Renée C. Myers, Florian Augustin, Jérémy Huard et al. · CPT Pharmacometrics & Systems Pharmacology Open access 16 Jun 2023 21
35 From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology Modeling in Cancer Immunotherapy Vincent Lemaire, David M. Bassen, Mike Reed et al. · Clinical Pharmacology & Therapeutics Open access 25 Oct 2022 20
36 A Flexible Approach for Context‐Dependent Assessment of Quantitative Systems Pharmacology Models Saroja Ramanujan, Jason R. Chan, Christina M. Friedrich et al. · CPT Pharmacometrics & Systems Pharmacology Open access 15 Apr 2019 20
37 Pharmacometabolomic signature links simvastatin therapy and insulin resistance Mona Elbadawi-Sidhu, Rebecca Baillie, Hongjie Zhu et al. · Metabolomics Open access 23 Dec 2016 19
38 Pharmacokinetic analysis of 14C‐ursodiol in newborn infants using accelerator mass spectrometry Toufigh Gordi, Rebecca Baillie, Le Thuy Vuong et al. · The Journal of Clinical Pharmacology 8 May 2014 19
39 Pharmacometabolomics Informs About Pharmacokinetic Profile of Methylphenidate Rima F Kaddurah-Daouk, Thomas Hankemeier, Elizabeth H. Scholl et al. · CPT Pharmacometrics & Systems Pharmacology Open access Aug 2018 17
40 A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque Characteristics Jeffrey E. Ming, Ruth E. Abrams, Derek W. Bartlett et al. · Gene Regulation and Systems Biology Open access 2017 17
41 Virtual Systems Pharmacology (ViSP) software for simulation from mechanistic systems-level models Sergey Vasilyevich Ermakov, Peter Forster, Jyotsna Pagidala et al. · Frontiers in Pharmacology Open access 22 Oct 2014 17
42 A capacidade de leitos hospitalares no Brasil, as internações no SUS, a migração demográfica e os custos dos procedimentos Beny José Finkelstein, LCDS Borges · Jornal Brasileiro de Economia da Saúde Open access 20 Dec 2020 15
43 Quantitative systems pharmacology model‐based investigation of adverse gastrointestinal events associated with prolonged treatment with PI3‐kinase inhibitors Kapil G. Gadkar, Christina M. Friedrich, Vincent J. Hurez et al. · CPT Pharmacometrics & Systems Pharmacology Open access Dec 2021 14
44 Alterations in Acylcarnitines, Amines, and Lipids Inform about Mechanism of Action of Citalopram/Escitalopram in Major Depression Siamak MahmoudianDehkordi, Ahmed T. Ahmed, Sudeepa Bhattacharyya et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 10 Feb 2020 11
45 Quantitative Systems Pharmacology: Applications and Adoption in Drug Development Saroja Ramanujan, Kapil G. Gadkar, Ananth Kadambi · AAPS advances in the pharmaceutical sciences series Book chapter 2016 11
46 La educación para la salud: una propuesta fundamentada desde el campo de la docencia Valentín Gavidia Catalán, Ma J. Rodés Sala, A. Carratala Beguer · Enseñanza de las Ciencias Revista de investigación y experiencias didácticas Open access 15 Jan 1993 11
47 Steady-State Pharmacokinetics of Gabapentin after Administration of a Novel Gastroretentive Extended-Release Formulation in Postmenopausal Women with Vasomotor Symptoms Verne E. Cowles, Toufigh Gordi, Sui Yuen Eddie Hou · Clinical Drug Investigation Sep 2012 10
48 Synthesis of a novel cyclopropyl phosphonate nucleotide as a phosphate mimic Erich Altenhofer, Michael J. Lawler, Pankaj Kumar et al. · Chemical Communications 2021 8
49 Serum triglycerides in Alzheimer’s disease: Relation to neuroimaging and CSF biomarkers Megan M. Bernath, Sudeepa Bhattacharyya, Kwangsik T. Nho et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 13 Oct 2018 8
50 Virtual patients inspired by multiomics predict the efficacy of an anti-IFNα mAb in cutaneous lupus Vincent J. Hurez, Glenn Gauderat, Perrine Soret et al. · iScience Open access 6 Jan 2025 5

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.